Your browser doesn't support javascript.
loading
Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade.
Secondini, Chiara; Coquoz, Oriana; Spagnuolo, Lorenzo; Spinetti, Thibaud; Peyvandi, Sanam; Ciarloni, Laura; Botta, Francesca; Bourquin, Carole; Rüegg, Curzio.
Afiliação
  • Secondini C; Department of Medicine, Faculty of Science, University of Fribourg, Fribourg, Switzerland.
  • Coquoz O; Department of Medicine, Faculty of Science, University of Fribourg, Fribourg, Switzerland.
  • Spagnuolo L; Department of Medicine, Faculty of Science, University of Fribourg, Fribourg, Switzerland.
  • Spinetti T; School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Lausanne, Switzerland.
  • Peyvandi S; Department of Medicine, Faculty of Science, University of Fribourg, Fribourg, Switzerland.
  • Ciarloni L; Department of Medicine, Faculty of Science, University of Fribourg, Fribourg, Switzerland.
  • Botta F; School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Lausanne, Switzerland.
  • Bourquin C; School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Lausanne, Switzerland.
  • Rüegg C; Department of Medicine, Faculty of Science, University of Fribourg, Fribourg, Switzerland.
Oncoimmunology ; 6(6): e1316437, 2017.
Article em En | MEDLINE | ID: mdl-28680747

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article